Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough.
作者信息
Connolly S J
出版信息
BMJ. 2000 May 6;320(7244):1219-20. doi: 10.1136/bmj.320.7244.1219.
Abstract
摘要
相似文献
1
Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough.针对患有心房颤动且有中风风险因素的患者进行抗凝治疗。华法林可将风险降低三分之二，但医生的处方量仍不足。
BMJ. 2000 May 6;320(7244):1219-20. doi: 10.1136/bmj.320.7244.1219.
2
Anticoagulation for Nonvalvular Atrial Fibrillation: Influence of Epidemiologic Trends and Clinical Practice Patterns on Risk Stratification and Net Clinical Benefit.非瓣膜性心房颤动的抗凝治疗：流行病学趋势和临床实践模式对风险分层及净临床获益的影响
Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). doi: 10.1161/CIRCOUTCOMES.117.003669.
3
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?心房颤动中口服抗凝剂的使用欠佳：直接口服抗凝剂的引入是否改善了处方实践？
Am J Cardiovasc Drugs. 2016 Jun;16(3):183-200. doi: 10.1007/s40256-016-0161-8.
4
Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.中国非瓣膜性心房颤动急性缺血性脑卒中患者出院时华法林的使用情况。
Stroke. 2016 Feb;47(2):464-70. doi: 10.1161/STROKEAHA.115.011833. Epub 2015 Dec 22.
5
Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动患者卒中预防的住院医师抗凝选择。
Can J Cardiol. 2016 Jun;32(6):824-8. doi: 10.1016/j.cjca.2015.08.004. Epub 2015 Aug 14.
6
Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.心房颤动患者抗凝治疗的障碍：不断变化的医生相关因素。
Stroke. 2008 Jan;39(1):7-9. doi: 10.1161/STROKEAHA.107.496554. Epub 2007 Nov 29.
7
[Anticoagulation with atrial fibrillation].[心房颤动的抗凝治疗]
Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):89-94. doi: 10.1007/s00399-006-0515-z.
8
The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.塔斯马尼亚心房颤动研究：2011 - 2015年向直接口服抗凝剂的转变
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12254.
9
Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.直接口服抗凝剂与华法林用于非瓣膜性心房颤动的使用和比较效果的时间趋势：一项加拿大基于人群的研究。
J Am Heart Assoc. 2017 Oct 28;6(11):e007129. doi: 10.1161/JAHA.117.007129.
10
Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives.心力衰竭合并心房颤动患者抗凝治疗依从性的障碍与促进因素：患者及医疗服务提供者的观点
J Clin Nurs. 2017 Dec;26(23-24):4325-4334. doi: 10.1111/jocn.13759. Epub 2017 Mar 31.
引用本文的文献
1
A survey of opinion: When to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation?观点调查：急性缺血性中风合并心房颤动患者何时开始口服抗凝药治疗？
Eur Stroke J. 2018 Dec;3(4):355-360. doi: 10.1177/2396987318787124. Epub 2018 Jul 10.
2
[Characteristics of oral anti-coagulation treatment in high-risk chronic auricular fibrillation].[高危慢性心房颤动患者口服抗凝治疗的特点]
Aten Primaria. 2004 Nov 15;34(8):414-9. doi: 10.1016/s0212-6567(04)78925-8.
3
Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods.两种即时检验系统国际标准化比值的可靠性：与传统方法的比较。
BMJ. 2003 Jul 5;327(7405):30. doi: 10.1136/bmj.327.7405.30.
4
[Effectiveness of an intervention programme to improve oral anti-coagulation treatment for patients with chronic auricular fibrillation in a health district].[一项改善某健康区慢性心房颤动患者口服抗凝治疗的干预项目的效果]
Aten Primaria. 2002 Nov 30;30(9):588-9. doi: 10.1016/s0212-6567(02)79111-7.
5
6
Anticoagulation for patients with atrial fibrillation. Editorial may have overinterpreted data.心房颤动患者的抗凝治疗。社论可能过度解读了数据。
BMJ. 2000 Sep 9;321(7261):638-9. doi: 10.1136/bmj.321.7261.638.
本文引用的文献
1
Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.一项前瞻性队列研究，以确定心房颤动中风预防的抗凝试验疗效是否能转化为临床有效性。
BMJ. 2000 May 6;320(7244):1236-9. doi: 10.1136/bmj.320.7244.1236.
2
Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.在全科医疗中实施循证医学：心房颤动抗栓治疗的审计与定性研究
BMJ. 1999 May 15;318(7194):1324-7. doi: 10.1136/bmj.318.7194.1324.
3
Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.社区中房颤的患病率及抗凝治疗的适用性
Lancet. 1998 Oct 10;352(9135):1167-71. doi: 10.1016/S0140-6736(98)01401-9.
4
Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.
Can J Cardiol. 1998 May;14(5):695-702.
5
National patterns of warfarin use in atrial fibrillation.心房颤动患者华法林使用的全国模式。
Arch Intern Med. 1996;156(22):2537-41.
6
7
8
Antithrombotic therapy in atrial fibrillation.心房颤动的抗栓治疗
Chest. 1995 Oct;108(4 Suppl):352S-359S. doi: 10.1378/chest.108.4_supplement.352s.
Zotero 插件